The International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) is a global federation of clinical research networks, providing a proficient, coordinated, and agile research response to outbreak-prone infectious diseases to prevent illness and deaths from infectious diseases outbreaks. Patient-based research must be at the heart of an evidence-based response to epidemic infections. A grass-roots federation of clinical investigators is needed to generate the evidence to improve clinical care and public health responses, and to support the development and evaluation of new diagnostics, drugs and vaccines.
Since ISARIC’s inception in 2011, the need for more intensified and structural international coordination and collaboration has gained momentum and this changing international landscape, of increased coordination and collaboration, requires an equal response from the international clinical research community, to ensure there is a clear and complete pathway from bedside to bench and back. Provision of the operational capabilities to conduct clinical research, whenever and wherever needed, is the role that ISARIC aspires to have, by its members and for its members.
COVID-19 Clinical Research Coalition
Alongside DNDi, IDDO is part of the facilitating committee of the global COVID-19 Clinical Research Coalition formed to accelerate the urgent research on prevention, diagnosis needed to address COVID-19 in resource-limited settings.
Drugs for Neglected Diseases initiative (DNDi) is a collaborative, patients’ needs-driven, non-profit drug research and development (R&D) organisation that is developing new treatments for neglected diseases.
The World Health Organization’s Global Outbreak Alert and Response Network (GOARN) is a collaboration of existing institutions and networks that have the right technical expertise and skills to respond when they are needed most. Both IDDO and ISARIC are part of the network that pools human and technical resources for rapid identification, confirmation and response to outbreaks of international importance.
Addressing a global pandemic requires global collaboration. To facilitate this, Exaptive, in collaboration with the Bill & Melinda Gates Foundation, has created the COVID-19 Cognitive City. Cognitive City is a data-centric social network with a goal. The goal of this cognitive city is to increase communication in order to stop the spread of COVID-19 and accelerate development of a vaccine.
The Mahidol Oxford Tropical Medicine Research Unit (MORU) is a research collaboration between Mahidol University (Thailand), the University of Oxford and Wellcome (UK).
Nuffield Department of Medicine
The Nuffield Department of Medicine (NDM) is a large multi-disciplinary department that links high quality clinical research with medical application. The underpinning motivation behind all research carried out by NDM is the pursuit of academic excellence and the positive impact of research on the health and wellbeing of the global community.
For further information please contact us at: firstname.lastname@example.org